Instil Bio, (id:8375 TIL)
26.15 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 7:18:46 PM)
Exchange closed, opens in 14 hours 11 minutes
6.76 USD (6.76%)
-1.32 USD (-1.32%)
-35.91 USD (-35.91%)
141.91 USD (141.91%)
253.38 USD (253.38%)
-95.16 USD (-95.16%)
About Instil Bio,
Market Capitalization 170.65M
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
| Headquarters (address) |
3963 Maple Avenue Dallas 75219 TX United States |
| Phone | 972 499 3350 |
| Website | https://instilbio.com |
| Employees | 49 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | TIL |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 6.08 - 92.00 |
| Market Capitalization | 170.65M |
| P/E trailing | -1.09 |
| P/E forward | -2.17 |
| Price/Book | 0.753 |
| Beta | 1.74 |
| EPS | -11.56 |
| EPS United States (ID:6, base:3402) | 24.22 |